Cetera Trust Company, N.A Care Dx, Inc. Transaction History
Cetera Trust Company, N.A
- $166 Billion
- Q1 2024
A detailed history of Cetera Trust Company, N.A transactions in Care Dx, Inc. stock. As of the latest transaction made, Cetera Trust Company, N.A holds 11,870 shares of CDNA stock, worth $173,539. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,870
Previous 11,870
-0.0%
Holding current value
$173,539
Previous $142 Million
11.75%
% of portfolio
0.08%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$85.7 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$79.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$62.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$61.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$57.5 Million0.65% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $782M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...